Nasacort aq and Reglan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasacort aq and Reglan. Common interactions include leukocytosis among females and dry skin among males.

The phase IV clinical study analyzes what interactions people who take Nasacort aq and Reglan have. It is created by eHealthMe based on reports of 29 people who take Nasacort aq and Reglan from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 27, 2022

29 people who take Nasacort aq and Reglan together, and have interactions are studied.


What is Nasacort aq?

Nasacort aq has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 1,433 Nasacort aq users for its effectiveness, alternative drugs and more.

What is Reglan?

Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 28,535 Reglan users for its effectiveness, alternative drugs and more.

Number of Nasacort aq and Reglan reports submitted per year:

Nasacort aq and Reglan drug interactions.

Common Nasacort Aq and Reglan drug interactions by gender *:

female:

  1. Leukocytosis
  2. Lung neoplasm
  3. Myositis
  4. Nasal polyps
  5. Nasal septum deviation
  6. Pain
  7. Paranasal cyst
  8. Pericardial effusion
  9. Pleuritic pain
  10. Abdominal pain

male:

  1. Dry skin
  2. Joint range of motion decreased
  3. Skin induration
  4. Back pain
  5. Bone marrow depression
  6. Depression
  7. Hypoaesthesia
  8. Joint swelling
  9. Neck pain
  10. Pain in extremity

Common Nasacort Aq and Reglan drug interactions by age *:

0-1:

n/a

2-9:

  1. Bone marrow depression

10-19:

  1. Electrocardiogram qt prolonged

20-29:

n/a

30-39:

  1. Convulsion
  2. Infusion site pain
  3. Syncope

40-49:

  1. Abdominal pain
  2. Cough
  3. Hypersensitivity
  4. Asthma
  5. Dyspnoea
  6. Anaphylactic reaction
  7. Asthenia
  8. Atelectasis
  9. Blood culture positive
  10. Bone cyst

50-59:

  1. Hyperlipidaemia
  2. Metabolic syndrome
  3. Obesity
  4. Paranoia
  5. Sinus congestion
  6. Sleep disorder
  7. Social avoidant behaviour
  8. Somnolence
  9. Tendonitis
  10. Tooth abscess

60+:

  1. Dry skin
  2. Joint range of motion decreased
  3. Skin induration
  4. Back pain
  5. Dizziness
  6. Pain in extremity
  7. Blood cholesterol increased
  8. Cardiac failure congestive
  9. Hypertension
  10. Myocardial infarction

Common conditions people have *:

  1. Asthma: 13 people, 44.83%
  2. Depression: 8 people, 27.59%
  3. Headache (pain in head): 8 people, 27.59%
  4. Hypersensitivity: 8 people, 27.59%
  5. Pain: 7 people, 24.14%
  6. Migraine (headache): 7 people, 24.14%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 24.14%
  8. Stress And Anxiety: 6 people, 20.69%
  9. Sinusitis (inflammation of sinus): 5 people, 17.24%
  10. Rickets (softening of bones): 5 people, 17.24%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort aq and Reglan?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Nasacort aq and Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Nasacort aq side effects:

Browse all side effects of Nasacort aq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Reglan side effects:

Browse all side effects of Reglan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Nasacort aq interactions:

Browse all interactions between Nasacort aq and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Reglan interactions:

Browse all interactions between Reglan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone acetonide and metoclopramide hydrochloride (the active ingredients of Nasacort aq and Reglan, respectively), and Nasacort aq and Reglan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Nasacort aq and Reglan.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: